{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T07:39:59Z","timestamp":1766475599195,"version":"3.48.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-025-01761-0","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T07:37:34Z","timestamp":1766475454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of apolipoprotein E4 in alzheimer\u2019s disease pathogenesis and emerging therapeutic strategies"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6420-7509","authenticated-orcid":false,"given":"Sribha","family":"Natarajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7693-0322","authenticated-orcid":false,"given":"Saraswathy","family":"Sundara Dhakshinamurthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"issue":"3","key":"1761_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12498","volume":"10","author":"S Abushakra","year":"2024","unstructured":"Abushakra S, Porsteinsson AP, Sabbagh M, Watson D, Power A, Liang E, MacSweeney E, Boada M, Flint S, McLaine R, Kesslak JP, Hey JA, Tolar M (2024) Apolloe4 phase 3 study of oral ALZ-801\/valiltramiprosate in APOE \u03b54\/\u03b54 homozygotes with early Alzheimer\u2019s disease: trial design and baseline characteristics. Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions 10(3):e12498. https:\/\/doi.org\/10.1002\/trc2.12498","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"issue":"4","key":"1761_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/BIOM12040499\/S1","volume":"12","author":"JA Aguilar-Pineda","year":"2022","unstructured":"Aguilar-Pineda JA, Paco-Coralla SG, Febres-Molina C, Gamero-Begazo PL, Shrivastava P, Vera-L\u00f3pez KJ, Davila-Del-carpio G, L\u00f3pez-C P, G\u00f3mez B, Lino Cardenas CL (2022) In silico analysis of the antagonist effect of enoxaparin on the APOE4\u2013amyloid-beta (A\u03b2) complex at different pH conditions. Biomolecules 12(4):499. https:\/\/doi.org\/10.3390\/BIOM12040499\/S1","journal-title":"Biomolecules"},{"issue":"S9","key":"1761_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/ALZ.044511","volume":"16","author":"PS Aisen","year":"2020","unstructured":"Aisen PS, Zhou J, Irizarry MC, Kramer LD, Swanson CJ, Dhadda S, Rabe M, Krause S, Li DJ, Raman R, Donohue MC, Sethuraman G, Johnson KA, Sperling RA (2020) AHEAD 3\u201345 study design: a global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer\u2019s disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial). Alzheimers Dement 16(S9):e044511. https:\/\/doi.org\/10.1002\/ALZ.044511","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1761_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S40504-020-00106-2","volume":"16","author":"M Angrist","year":"2020","unstructured":"Angrist M, Yang A, Kantor B, Chiba-Falek O (2020) Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer\u2019s disease. Life Sci Soc Policy 16(1):1\u201311. https:\/\/doi.org\/10.1186\/S40504-020-00106-2","journal-title":"Life Sci Soc Policy"},{"key":"1761_CR5","doi-asserted-by":"publisher","DOI":"10.1101\/460899","author":"YWA Huang","year":"2018","unstructured":"Huang YWA, Zhou B, Nabet AM, Wernig M, S\u00fcdhof TC (2018) ApoE2, ApoE3 and ApoE4 differentially impact multiple signaling pathways regulating synaptogenesis. bioRxiv. https:\/\/doi.org\/10.1101\/460899","journal-title":"bioRxiv"},{"issue":"1","key":"1761_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13195-020-00710-6\/FIGURES\/5","volume":"12","author":"MS Baek","year":"2020","unstructured":"Baek MS, Cho H, Lee HS, Lee JH, Ryu YH, Lyoo CH (2020) Effect of APOE \u03b54 genotype on amyloid-betaand tau accumulation in Alzheimer\u2019s disease. Alzheimers Res Ther 12(1):1\u201312. https:\/\/doi.org\/10.1186\/S13195-020-00710-6\/FIGURES\/5","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1761_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13024-025-00843-Y","volume":"20","author":"AA Belaidi","year":"2025","unstructured":"Belaidi AA, Bush AI, Ayton S (2025) Apolipoprotein E in Alzheimer\u2019s disease: molecular insights and therapeutic opportunities. Mol Neurodegener 20(1):1\u201321. https:\/\/doi.org\/10.1186\/S13024-025-00843-Y","journal-title":"Mol Neurodegener"},{"issue":"4","key":"1761_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.14283\/JPAD.2018.35","volume":"5","author":"CL Berkowitz","year":"2018","unstructured":"Berkowitz CL, Mosconi L, Rahman A, Scheyer O, Hristov H, Isaacson RS (2018) Clinical application of APOE in Alzheimer\u2019s prevention: a precision medicine approach. J Prev Alzheimers Dis 5(4):245\u2013252. https:\/\/doi.org\/10.14283\/JPAD.2018.35","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"1761_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-025-96531-4","volume":"15","author":"E di Biase","year":"2025","unstructured":"di Biase E, Connolly KJ, Crumpton I, Cooper O, Hallett PJ, Isacson O (2025) ApoE4 requires lipidation enhancement to resolve cellular lipid and protein abnormalities following NPC1 inhibition. Sci Rep 15(1):1\u201322. https:\/\/doi.org\/10.1038\/s41598-025-96531-4","journal-title":"Sci Rep"},{"issue":"1","key":"1761_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13195-022-00992-Y\/FIGURES\/3","volume":"14","author":"J Blackman","year":"2022","unstructured":"Blackman J, Love S, Sinclair L, Cain R, Coulthard E (2022) APOE \u03b54, Alzheimer\u2019s disease neuropathology and sleep disturbance, in individuals with and without dementia. Alzheimers Res Ther 14(1):1\u201311. https:\/\/doi.org\/10.1186\/S13195-022-00992-Y\/FIGURES\/3","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1761_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/S13195-021-00927-Z","volume":"13","author":"P van Bokhoven","year":"2021","unstructured":"van Bokhoven P, de Wil A, Vermunt L, Leferink PS, Heetveld S, Cummings J, Scheltens P, Vijverberg EGB (2021) The Alzheimer\u2019s disease drug development landscape. Alzheimers Res Ther 13(1):186. https:\/\/doi.org\/10.1186\/S13195-021-00927-Z","journal-title":"Alzheimers Res Ther"},{"issue":"10","key":"1761_CR12","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","volume":"24","author":"WJ Brecht","year":"2004","unstructured":"Brecht WJ, Harris FM, Chang S, Tesseur I, Yu GQ, Xu Q, Fish JD, Wyss-Coray T, Buttini M, Mucke L, Mahley RW, Huang Y (2004) Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci 24(10):2527\u20132534. https:\/\/doi.org\/10.1523\/JNEUROSCI.4315-03.2004","journal-title":"J Neurosci"},{"issue":"12","key":"1761_CR13","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1523\/JNEUROSCI.19-12-04867.1999","volume":"19","author":"M Buttini","year":"1999","unstructured":"Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, Mucke L, Mahley RW (1999) Expression of human apolipoprotein E3 or E4 in the brains ofAPOE\u2212\/\u2212 mice: isoform-specific effects on neurodegeneration. J Neurosci 19(12):4867\u20134880. https:\/\/doi.org\/10.1523\/JNEUROSCI.19-12-04867.1999","journal-title":"J Neurosci"},{"issue":"2","key":"1761_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2217\/1745509X.1.2.303","volume":"1","author":"R Cacabelos","year":"2005","unstructured":"Cacabelos R (2005) Pharmacogenomics, nutrigenomics and therapeutic optimization in Alzheimer\u2019s disease. Aging Health 1(2):303\u2013348. https:\/\/doi.org\/10.2217\/1745509X.1.2.303","journal-title":"Aging Health"},{"issue":"3","key":"1761_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/S00401-015-1388-1","volume":"129","author":"C Cantoni","year":"2015","unstructured":"Cantoni C, Bollman B, Licastro D, Xie M, Mikesell R, Schmidt R, Yuede CM, Galimberti D, Olivecrona G, Klein RS, Cross AH, Otero K, Piccio L (2015) TREM2 regulates microglial cell activation in response to demyelination in vivo. Acta Neuropathol 129(3):429\u2013447. https:\/\/doi.org\/10.1007\/S00401-015-1388-1","journal-title":"Acta Neuropathol"},{"issue":"51","key":"1761_CR16","doi-asserted-by":"publisher","first-page":"18694","DOI":"10.1073\/PNAS.0508254102","volume":"102","author":"S Chang","year":"2005","unstructured":"Chang S, Ma TR, Miranda RD, Balestra ME, Mahley RW, Huang Y (2005) Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc Natl Acad Sci U S A 102(51):18694\u201318699. https:\/\/doi.org\/10.1073\/PNAS.0508254102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"1761_CR17","doi-asserted-by":"publisher","first-page":"12011","DOI":"10.1073\/PNAS.0914984107","volume":"107","author":"Y Chen","year":"2010","unstructured":"Chen Y, Durakoglugil MS, Xian X, Herz J (2010) APOE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing APOE receptor recycling. Proc Natl Acad Sci U S A 107(26):12011\u201312016. https:\/\/doi.org\/10.1073\/PNAS.0914984107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1761_CR18","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202256467","volume":"24","author":"L Chernyaeva","year":"2023","unstructured":"Chernyaeva L, Ratti G, Teiril\u00e4 L, Fudo S, Rankka U, Pelkonen A, Korhonen P, Leskinen K, Keskitalo S, Salokas K, Gkolfinopoulou C (2023) Reduced binding of APOE4 to complement factor H promotes amyloid-\u03b2 oligomerization and neuroinflammation. EMBO Rep 24(7):e56467","journal-title":"EMBO Rep"},{"key":"1761_CR19","doi-asserted-by":"publisher","first-page":"1101452","DOI":"10.3389\/fphar.2023.1101452","volume":"14","author":"CE Conti Filho","year":"2023","unstructured":"Conti Filho CE, Loss LB, Marcolongo-Pereira C, Rossoni Junior JV, Barcelos RM, Chiarelli-Neto O, Silva BS, PassamaniAmbrosio R, Castro FC, Teixeira SF, Mezzomo NJ (2023) Advances in Alzheimer\u2019s disease\u2019s pharmacological treatment. Front Pharmacol 14:1101452","journal-title":"Front Pharmacol"},{"key":"1761_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/SCIENCE.1217697","author":"PE Cramer","year":"2012","unstructured":"Cramer PE, Cirrito JR, Wesson DW, Lee CYD, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden KR, Wilson DA, Landreth GE (2012) APOE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models. Science. https:\/\/doi.org\/10.1126\/SCIENCE.1217697","journal-title":"Science"},{"key":"1761_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/FNAGI.2022.845291","volume":"14","author":"JR Diaz","year":"2022","unstructured":"Diaz JR, Mart\u00e1-Ariza M, Khodadadi-Jamayran A, Heguy A, Tsirigos A, Pankiewicz JE, Sullivan PM, Sadowski MJ (2022) Apolipoprotein E4 effects a distinct transcriptomic profile and dendritic arbor characteristics in hippocampal neurons cultured in vitro. Front Aging Neurosci 14:845291. https:\/\/doi.org\/10.3389\/FNAGI.2022.845291","journal-title":"Front Aging Neurosci"},{"key":"1761_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/J.GENE.2019.05.030","volume":"707","author":"A Durmaz","year":"2019","unstructured":"Durmaz A, Kumral E, Durmaz B, Onay H, Aslan GI, Ozkinay F, Pehlivan S, Orman M, Cogulu O (2019) Genetic factors associated with the predisposition to late onset Alzheimer\u2019s disease. Gene 707:212\u2013215. https:\/\/doi.org\/10.1016\/J.GENE.2019.05.030","journal-title":"Gene"},{"key":"1761_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/FNAGI.2019.00014","volume":"10","author":"CG Fernandez","year":"2019","unstructured":"Fernandez CG, Hamby ME, McReynolds ML, Ray WJ (2019) The role of APOE4 in disrupting the homeostatic functions of astrocytes and microglia in aging and Alzheimer\u2019s disease. Front Aging Neurosci 10:434225. https:\/\/doi.org\/10.3389\/FNAGI.2019.00014","journal-title":"Front Aging Neurosci"},{"key":"1761_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/FNAGI.2022.838436","volume":"14","author":"KE Foley","year":"2022","unstructured":"Foley KE, Hewes AA, Garceau DT, Kotredes KP, Carter GW, Sasner M, Howell GR (2022) The APOE\u03b53\/\u03b54 genotype drives distinct gene signatures in the cortex of young mice. Front Aging Neurosci 14:838436. https:\/\/doi.org\/10.3389\/FNAGI.2022.838436","journal-title":"Front Aging Neurosci"},{"key":"1761_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/J.NBD.2025.106983","volume":"212","author":"CM Friday","year":"2025","unstructured":"Friday CM, Stephens IO, Smith CT, Lee S, Satish D, Devanney NA, Cohen S, Morganti JM, Gordon SM, Johnson LA (2025) APOE4 reshapes the lipid droplet proteome and modulates microglial inflammatory responses. Neurobiol Dis 212:106983. https:\/\/doi.org\/10.1016\/J.NBD.2025.106983","journal-title":"Neurobiol Dis"},{"issue":"27","key":"1761_CR26","doi-asserted-by":"publisher","first-page":"25754","DOI":"10.1074\/JBC.M502143200","volume":"280","author":"JD Fryer","year":"2005","unstructured":"Fryer JD, DeMattos RB, McCormick LM, O\u2019Dell MA, Spinner ML, Bales KR, Paul SM, Sullivan PM, Parsadanian M, Bu G, Holtzman DM (2005) The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPPMice. J Biol Chem 280(27):25754\u201325759. https:\/\/doi.org\/10.1074\/JBC.M502143200","journal-title":"J Biol Chem"},{"issue":"1","key":"1761_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/620793","volume":"2013","author":"M Goyal","year":"2013","unstructured":"Goyal M, Grover S, Dhanjal JK, Goyal S, Tyagi C, Chacko S, Grover A (2013) Novel natural structure corrector of APOE4 for checking Alzheimer\u2019s disease: benefits from high throughput screening and molecular dynamics simulations. Biomed Res Int 2013(1):620793. https:\/\/doi.org\/10.1155\/2013\/620793","journal-title":"Biomed Res Int"},{"key":"1761_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/J.JNEUROIM.2020.577315","volume":"346","author":"D Graykowski","year":"2020","unstructured":"Graykowski D, Kasparian K, Caniglia J, Gritsaeva Y, Cudaback E (2020) Neuroinflammation drives APOE genotype-dependent differential expression of neprilysin. J Neuroimmunol 346:577315. https:\/\/doi.org\/10.1016\/J.JNEUROIM.2020.577315","journal-title":"J Neuroimmunol"},{"issue":"11","key":"1761_CR29","doi-asserted-by":"publisher","first-page":"e797","DOI":"10.1016\/S2666-7568(22)00219-7","volume":"3","author":"S Gregory","year":"2022","unstructured":"Gregory S, Saunders S, Ritchie CW (2022) Science disconnected: the translational gap between basic science, clinical trials, and patient care in Alzheimer\u2019s disease. Lancet Healthy Longev 3(11):e797\u2013e803. https:\/\/doi.org\/10.1016\/S2666-7568(22)00219-7","journal-title":"Lancet Healthy Longev"},{"key":"1761_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/FBIOE.2023.1143157","volume":"11","author":"C Guo","year":"2023","unstructured":"Guo C, Ma X, Gao F, Guo Y (2023) Off-target effects in CRISPR\/Cas9 gene editing. Front Bioeng Biotechnol 11:1143157. https:\/\/doi.org\/10.3389\/FBIOE.2023.1143157","journal-title":"Front Bioeng Biotechnol"},{"issue":"4","key":"1761_CR31","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/JAPP.12249","volume":"34","author":"C Gyngell","year":"2017","unstructured":"Gyngell C, Douglas T, Savulescu J (2017) The ethics of germline gene editing. J Appl Philos 34(4):498\u2013513. https:\/\/doi.org\/10.1111\/JAPP.12249","journal-title":"J Appl Philos"},{"issue":"5","key":"1761_CR32","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/S00109-020-01893-Z","volume":"98","author":"HA Han","year":"2020","unstructured":"Han HA, Pang JKS, Soh BS (2020) Mitigating off-target effects in CRISPR\/Cas9-mediated in vivo gene editing. J Mol Med 98(5):615\u2013632. https:\/\/doi.org\/10.1007\/S00109-020-01893-Z","journal-title":"J Mol Med"},{"issue":"12","key":"1761_CR33","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/ALZ.12756","volume":"18","author":"O Hansson","year":"2022","unstructured":"Hansson O, Edelmayer RM, Boxer AL, Carrillo MC, Mielke MM, Rabinovici GD, Salloway S, Sperling R, Zetterberg H, Teunissen CE (2022) The Alzheimer\u2019s Association appropriate use recommendations for blood biomarkers in Alzheimer\u2019s disease. Alzheimers Dement 18(12):2669\u20132686. https:\/\/doi.org\/10.1002\/ALZ.12756","journal-title":"Alzheimers Dement"},{"issue":"5","key":"1761_CR34","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1001\/ARCHNEUROL.2011.845","volume":"69","author":"D Head","year":"2012","unstructured":"Head D, Bugg JM, Goate AM, Fagan AM, Mintun MA, Benzinger T, Holtzman DM, Morris JC (2012) Exercise engagement as a moderator of the effects of APOE genotype on amyloid deposition. Arch Neurol 69(5):636\u2013643. https:\/\/doi.org\/10.1001\/ARCHNEUROL.2011.845","journal-title":"Arch Neurol"},{"issue":"4","key":"1761_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14(4):388\u2013405. https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5","journal-title":"Lancet Neurol"},{"issue":"2","key":"1761_CR36","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3233\/JAD-180859","volume":"71","author":"Z Hobel","year":"2019","unstructured":"Hobel Z, Isenberg AL, Raghupathy D, MacK W, Pa J, Zhao L (2019) APOE \u03f54 gene dose and sex effects on Alzheimer\u2019s disease MRI biomarkers in older adults with mild cognitive impairment. J Alzheimers Dis 71(2):647\u2013658. https:\/\/doi.org\/10.3233\/JAD-180859","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1761_CR37","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1073\/PNAS.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, Mackey B, Olney J, McKeel D, Wozniak D, Paul SM (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 97(6):2892\u20132897. https:\/\/doi.org\/10.1073\/PNAS.050004797","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1761_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/BIOMEDICINES10071495\/S1","volume":"10","author":"BV Hong","year":"2022","unstructured":"Hong BV, Zheng J, Agus JK, Tang X, Lebrilla CB, Jin LW, Maezawa I, Erickson K, Harvey DJ, DeCarli CS, Mungas DM (2022) High-density lipoprotein changes in Alzheimer\u2019s disease are APOE genotype-specific. Biomedicines 10(7):1495. https:\/\/doi.org\/10.3390\/BIOMEDICINES10071495\/S1","journal-title":"Biomedicines"},{"key":"1761_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/FNAGI.2025.1535280\/FULL","volume":"17","author":"S Islam","year":"2025","unstructured":"Islam S, Noorani A, Sun Y, Michikawa M, Zou K (2025) Multi-functional role of apolipoprotein E in neurodegenerative diseases. Front Aging Neurosci 17:1535280. https:\/\/doi.org\/10.3389\/FNAGI.2025.1535280\/FULL","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"1761_CR40","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.ymthe.2024.03.024","volume":"32","author":"RJ Jackson","year":"2024","unstructured":"Jackson RJ, Keiser MS, Meltzer JC, Fykstra DP, Dierksmeier SE, Hajizadeh S, Kreuzer J, Morris R, Melloni A, Nakajima T, Tecedor L, Ranum PT, Carrell E, Chen YH, Nishtar MA, Holtzman DM, Haas W, Davidson BL, Hyman BT (2024) APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease. Mol Ther 32(5):1373\u20131386. https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.024","journal-title":"Mol Ther"},{"issue":"2","key":"1761_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0054713","volume":"8","author":"EG Jacobs","year":"2013","unstructured":"Jacobs EG, Kroenke C, Lin J, Epel ES, Kenna HA, Blackburn EH, Rasgon NL (2013) Accelerated cell aging in female APOE-\u03b54 carriers: implications for hormone therapy use. PLoS One 8(2):e54713. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0054713","journal-title":"PLoS One"},{"issue":"5","key":"1761_CR42","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/J.NEURON.2008.04.010","volume":"58","author":"Q Jiang","year":"2008","unstructured":"Jiang Q, Lee CYD, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B, Willson TM, Collins JL, Richardson JC, Smith JD, Comery TA, Riddell D, Holtzman DM, Tontonoz P, Landreth GE (2008) APOE promotes the proteolytic degradation of A\u03b2. Neuron 58(5):681\u2013693. https:\/\/doi.org\/10.1016\/J.NEURON.2008.04.010","journal-title":"Neuron"},{"issue":"1","key":"1761_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-022-01020-9","volume":"14","author":"NR Johnson","year":"2022","unstructured":"Johnson NR, Wang ACJ, Coughlan C, Sillau S, Lucero E, Viltz L, Markham N, Allen C, Dhanasekaran AR, Chial HJ, Potter H (2022) Imipramine and olanzapine block APOE4-catalyzed polymerization of A\u03b2 and show evidence of improving Alzheimer\u2019s disease cognition. Alzheimers Res Ther 14(1):1\u201323","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"1761_CR44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1046\/J.1529-8817.2004.00110.X","volume":"68","author":"MI Kamboh","year":"2004","unstructured":"Kamboh MI (2004) Molecular genetics of late-onset Alzheimer\u2019s disease. Ann Hum Genet 68(4):381\u2013404. https:\/\/doi.org\/10.1046\/J.1529-8817.2004.00110.X","journal-title":"Ann Hum Genet"},{"issue":"2","key":"1761_CR45","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3233\/JAD-150348","volume":"48","author":"JT-R Keeney","year":"2015","unstructured":"Keeney JT-R, Ibrahimi S, Zhao L (2015) Human APOE isoforms differentially modulate glucose and amyloid metabolic pathways in female brain: evidence of the mechanism of neuroprotection by APOE2 and implications for Alzheimer\u2019s disease prevention and early intervention. J Alzheimers Dis 48(2):411\u2013424. https:\/\/doi.org\/10.3233\/JAD-150348","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"1761_CR46","doi-asserted-by":"publisher","first-page":"767","DOI":"10.14348\/MOLCELLS.2014.0248","volume":"37","author":"J Kim","year":"2014","unstructured":"Kim J, Yoon H, Basak J, Kim J (2014) Apolipoprotein E in synaptic plasticity and Alzheimer\u2019s disease: potential cellular and molecular mechanisms. Mol Cells 37(11):767\u2013776. https:\/\/doi.org\/10.14348\/MOLCELLS.2014.0248","journal-title":"Mol Cells"},{"issue":"49","key":"1761_CR47","doi-asserted-by":"publisher","first-page":"18007","DOI":"10.1523\/JNEUROSCI.3773-11.2011","volume":"31","author":"J Kim","year":"2011","unstructured":"Kim J, Jiang H, Park S, Eltorai AEM, Stewart FR, Yoon H, Basak JM, Finn MB, Holtzman DM (2011) Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-betaAmyloidosis. J Neurosci 31(49):18007\u201318012. https:\/\/doi.org\/10.1523\/JNEUROSCI.3773-11.2011","journal-title":"J Neurosci"},{"key":"1761_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cells12212512","author":"K Kirchner","year":"2023","unstructured":"Kirchner K, Garvert L, K\u00fchn L, Bonk S, Grabe HJ, van der Auwera S (2023) Detrimental effects of ApoE \u03b54 on blood-brain barrier integrity and their potential implications on the pathogenesis of Alzheimer\u2019s disease. Cells. https:\/\/doi.org\/10.3390\/cells12212512","journal-title":"Cells"},{"issue":"1","key":"1761_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/731526","volume":"2012","author":"M Kolarova","year":"2012","unstructured":"Kolarova M, Garc\u00eda-Sierra F, Bartos A, Ricny J, Ripova D (2012) Structure and pathology of tau protein in Alzheimer disease. Int J Alzheimers Dis 2012(1):731526. https:\/\/doi.org\/10.1155\/2012\/731526","journal-title":"Int J Alzheimers Dis"},{"issue":"7603","key":"1761_CR50","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR (2016) Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533(7603):420\u2013424. https:\/\/doi.org\/10.1038\/nature17946","journal-title":"Nature"},{"issue":"1","key":"1761_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-4-21","volume":"4","author":"KM Korwek","year":"2009","unstructured":"Korwek KM, Trotter JH, Ladu MJ, Sullivan PM, Weeber EJ (2009) APOE isoform-dependent changes in hippocampal synaptic function. Mol Neurodegener 4(1):1\u201318. https:\/\/doi.org\/10.1186\/1750-1326-4-21","journal-title":"Mol Neurodegener"},{"issue":"4","key":"1761_CR52","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/J.NEURON.2014.08.005","volume":"83","author":"C Lane-Donovan","year":"2014","unstructured":"Lane-Donovan C, Philips GT, Herz J (2014) More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration. Neuron 83(4):771\u2013787. https:\/\/doi.org\/10.1016\/J.NEURON.2014.08.005","journal-title":"Neuron"},{"issue":"17","key":"1761_CR53","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.3390\/IJMS21176336","volume":"21","author":"MF Lanfranco","year":"2020","unstructured":"Lanfranco MF, Ng CA, Rebeck GW (2020) ApoE lipidation as a therapeutic target in Alzheimer\u2019s disease. Int J Mol Sci 21(17):6336\u20136336. https:\/\/doi.org\/10.3390\/IJMS21176336","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1761_CR54","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S1474-4422(18)30053-X","volume":"17","author":"SJ van der Lee","year":"2018","unstructured":"van der Lee SJ, Wolters FJ, Ikram MK, Hofman A, Ikram MA, Amin N, van Duijn CM (2018) The effect of APOE and other common genetic variants on the onset of Alzheimer\u2019s disease and dementia: a community-based cohort study. Lancet Neurol 17(5):434\u2013444. https:\/\/doi.org\/10.1016\/S1474-4422(18)30053-X","journal-title":"Lancet Neurol"},{"issue":"12","key":"1761_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S00018-023-05026-W","volume":"80","author":"E Lewkowicz","year":"2023","unstructured":"Lewkowicz E, Nakamura MN, Rynkiewicz MJ, Gursky O (2023) Molecular modeling of apoE in complexes with Alzheimer\u2019s amyloid-\u03b2 fibrils from human brain suggests a structural basis for apolipoprotein co-deposition with amyloids. Cell Mol Life Sci 80(12):1\u201319. https:\/\/doi.org\/10.1007\/S00018-023-05026-W","journal-title":"Cell Mol Life Sci"},{"key":"1761_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/S13024-020-00413-4","author":"Z Li","year":"2020","unstructured":"Li Z, Shue F, Zhao N, Shinohara M, Bu G (2020) APOE2: protective mechanism and therapeutic implications for Alzheimer\u2019s disease. Mol Neurodegener. https:\/\/doi.org\/10.1186\/S13024-020-00413-4","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1761_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13578-021-00563-Y\/FIGURES\/6","volume":"11","author":"T Liang","year":"2021","unstructured":"Liang T, Hang W, Chen J, Wu Y, Wen B, Xu K, Ding B, Chen J (2021) APOE4 (\u0394272\u2013299) induces mitochondrial-associated membrane formation and mitochondrial impairment by enhancing GRP75-modulated mitochondrial calcium overload in neuron. Cell Biosci 11(1):1\u201314. https:\/\/doi.org\/10.1186\/S13578-021-00563-Y\/FIGURES\/6","journal-title":"Cell Biosci"},{"key":"1761_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/S13024-016-0107-2","author":"LY Lin","year":"2016","unstructured":"Lin LY, Zhang J, Dai XM, Xiao NA, Wu XL, Wei Z, Fang WT, Zhu YG, Chen XC (2016) Early-life stress leads to impaired spatial learning and memory in middle-aged APOE4-TR mice. Mol Neurodegener. https:\/\/doi.org\/10.1186\/S13024-016-0107-2","journal-title":"Mol Neurodegener"},{"key":"1761_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/FNAGI.2024.1420731\/FULL","volume":"16","author":"C Lin","year":"2024","unstructured":"Lin C, Kong Y, Chen Q, Zeng J, Pan X, Miao J (2024) Decoding sTREM2: its impact on Alzheimer\u2019s disease \u2013 a comprehensive review of mechanisms and implications. Front Aging Neurosci 16:1420731. https:\/\/doi.org\/10.3389\/FNAGI.2024.1420731\/FULL","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"1761_CR60","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/J.NEURON.2018.05.008","volume":"98","author":"YT Lin","year":"2018","unstructured":"Lin YT, Seo J, Gao F, Feldman HM, Wen HL, Penney J, Cam HP, Gjoneska E, Raja WK, Cheng J, Rueda R, Kritskiy O, Abdurrob F, Peng Z, Milo B, Yu CJ, Elmsaouri S, Dey D, Ko T, Tsai LH (2018) APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron 98(6):1141-1154.e7. https:\/\/doi.org\/10.1016\/J.NEURON.2018.05.008","journal-title":"Neuron"},{"issue":"5","key":"1761_CR61","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/ANA.26043","volume":"89","author":"A Litvinchuk","year":"2021","unstructured":"Litvinchuk A, Huynh TP, Shi Y, Jackson RJ, Finn MB, Manis M, Francis CM, Tran AC, Sullivan PM, Ulrich JD, Hyman BT (2021) Apolipoprotein E4 reduction with antisense oligonucleotides decreases neurodegeneration in a tauopathy model. Ann Neurol 89(5):952\u2013966. https:\/\/doi.org\/10.1002\/ANA.26043","journal-title":"Ann Neurol"},{"key":"1761_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2012.263","author":"C-C Liu","year":"2013","unstructured":"Liu C-C, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. https:\/\/doi.org\/10.1038\/nrneurol.2012.263","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"1761_CR63","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","volume":"96","author":"CC Liu","year":"2017","unstructured":"Liu CC, Zhao N, Fu Y, Wang N, Linares C, Tsai CW, Bu G (2017) APOE4 accelerates early seeding of amyloid pathology. Neuron 96(5):1024-1032.e3. https:\/\/doi.org\/10.1016\/j.neuron.2017.11.013","journal-title":"Neuron"},{"issue":"10248","key":"1761_CR64","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6\/ATTACHMENT\/DFC82F21-55AB-4950-8828-93F27077EF6D\/MMC1.PDF","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivim\u00e4ki M, Larson EB, Ogunniyi A, Mukadam N (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396(10248):413\u2013446. https:\/\/doi.org\/10.1016\/S0140-6736(20)30367-6\/ATTACHMENT\/DFC82F21-55AB-4950-8828-93F27077EF6D\/MMC1.PDF","journal-title":"Lancet"},{"issue":"49","key":"1761_CR65","doi-asserted-by":"publisher","first-page":"48529","DOI":"10.1074\/jbc.M306923200","volume":"278","author":"JR Lynch","year":"2003","unstructured":"Lynch JR, Tang W, Wang H, Vitek MP, Bennett ER, Sullivan PM, Warner DS, Laskowitz DT (2003) APOE genotype and an APOE-mimetic peptide modify the systemic and central nervous system inflammatory response. J Biol Chem 278(49):48529\u201348533. https:\/\/doi.org\/10.1074\/jbc.M306923200","journal-title":"J Biol Chem"},{"issue":"4852","key":"1761_CR66","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1126\/SCIENCE.3283935","volume":"240","author":"RW Mahley","year":"1988","unstructured":"Mahley RW (1988) Apolipoprotein e: cholesterol transport protein with expanding role in cell biology. Science 240(4852):622\u2013630. https:\/\/doi.org\/10.1126\/SCIENCE.3283935","journal-title":"Science"},{"issue":"12","key":"1761_CR67","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0022-2275(20)34443-6","volume":"25","author":"RW Mahley","year":"1984","unstructured":"Mahley RW, Innerarity TL, Rall SC, Weisgraber KH (1984) Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 25(12):1277\u20131294. https:\/\/doi.org\/10.1016\/S0022-2275(20)34443-6","journal-title":"J Lipid Res"},{"issue":"S5","key":"1761_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/ALZ.041482","volume":"16","author":"ER Mahoney","year":"2020","unstructured":"Mahoney ER, Dumitrescu L, Maki PM, Rapp SR, Dirk Keene C, Corrada MM, Hayden KM, Baker LD, Espeland MA, Resnick SM, Hohman TJ, Emily Mahoney CR (2020) Menopausal hormone therapy has beneficial effects on cognitive trajectories among homozygous carriers of the APOE-\u03b54 allele. Alzheimer\u2019s & Dementia 16(S5):e041482. https:\/\/doi.org\/10.1002\/ALZ.041482","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"1761_CR69","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/J.JALZ.2018.06.3063","volume":"15","author":"KA Matthews","year":"2019","unstructured":"Matthews KA, Xu W, Gaglioti AH, Holt JB, Croft JB, Mack D, McGuire LC (2019) Racial and ethnic estimates of Alzheimer\u2019s disease and related dementias in the United States (2015\u20132060) in adults aged \u226565 years. Alzheimers Dement 15(1):17\u201324. https:\/\/doi.org\/10.1016\/J.JALZ.2018.06.3063","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1761_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-5-16","volume":"5","author":"SS Minami","year":"2010","unstructured":"Minami SS, Cordova A, Cirrito JR, Tesoriero JA, Babus LW, Davis GC, Dakshanamurthy S, Turner RS, Pak DT, Rebeck GW, Paige M, Hoe HS (2010) ApoE mimetic peptide decreases A\u03b2 production in vitro and in vivo. Mol Neurodegener 5(1):1\u201312. https:\/\/doi.org\/10.1186\/1750-1326-5-16","journal-title":"Mol Neurodegener"},{"issue":"18","key":"1761_CR71","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMOA2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, Lo AC, Evans CD, Wessels AM, Ardayfio PA, Andersen SW, Shcherbinin S, Sparks J, Sims JR, Brys M, Apostolova LG, Salloway SP, Skovronsky DM (2021) Donanemab in early Alzheimer\u2019s disease. N Engl J Med 384(18):1691\u20131704. https:\/\/doi.org\/10.1056\/NEJMOA2100708","journal-title":"N Engl J Med"},{"issue":"22","key":"1761_CR72","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1097\/CM9.0000000000002480","volume":"135","author":"T Mu","year":"2022","unstructured":"Mu T, Wei J, Sun J, Jin J, Zhang T, Wu H, Su B (2022) Association of apolipoprotein E epsilon 4 and cognitive impairment in adults living with human immunodeficiency virus: a meta-analysis. Chin Med J 135(22):2677\u20132686. https:\/\/doi.org\/10.1097\/CM9.0000000000002480","journal-title":"Chin Med J"},{"issue":"9984","key":"1761_CR73","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu T, Lehtisalo J, Solomon A, Lev\u00e4lahti E, Ahtiluoto S, Antikainen R, B\u00e4ckman L, H\u00e4nninen T, Jula A, Laatikainen T, Lindstr\u00f6m J, Mangialasche F, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M (2015) A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385(9984):2255\u20132263. https:\/\/doi.org\/10.1016\/S0140-6736(15)60461-5","journal-title":"Lancet"},{"issue":"3","key":"1761_CR74","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/BCPT.14055","volume":"135","author":"J Poblano","year":"2024","unstructured":"Poblano J, Castillo-Tob\u00edas I, Berlanga L, Tamayo-Ordo\u00f1ez MC, del Carmen Rodr\u00edguez-Salazar M, Silva-Belmares SY, Aguayo-Morales H, Cobos-Puc LE (2024) Drugs targeting APOE4 that regulate beta-amyloid aggregation in the brain: therapeutic potential for Alzheimer\u2019s disease. Basic Clin Pharmacol Toxicol 135(3):237\u2013249. https:\/\/doi.org\/10.1111\/BCPT.14055","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"1761_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13024-022-00574-4","volume":"17","author":"A-C Raulin","year":"2022","unstructured":"Raulin A-C, Doss Sv, Trottier ZA, Ikezu TC, Bu G, Liu C-C (2022) APOE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegener 17(1):1\u201326. https:\/\/doi.org\/10.1186\/S13024-022-00574-4","journal-title":"Mol Neurodegener"},{"issue":"3","key":"1761_CR76","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0460.1000439","volume":"8","author":"TT Rohn","year":"2018","unstructured":"Rohn TT, Kim N, Isho NF, Mack JM (2018) The potential of CRISPR\/Cas9 gene editing as a treatment strategy for alzheimer\u2019s disease. J Alzheimers Dis Parkinsonism 8(3):439. https:\/\/doi.org\/10.4172\/2161-0460.1000439","journal-title":"J Alzheimers Dis Parkinsonism"},{"issue":"1","key":"1761_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12916-019-1299-4","volume":"17","author":"M Safieh","year":"2019","unstructured":"Safieh M, Korczyn AD, Michaelson DM (2019) APOE4: an emerging therapeutic target for Alzheimer\u2019s disease. BMC Med 17(1):1\u201317. https:\/\/doi.org\/10.1186\/S12916-019-1299-4","journal-title":"BMC Med"},{"issue":"1","key":"1761_CR78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/JAMANEUROL.2021.4161","volume":"79","author":"S Salloway","year":"2022","unstructured":"Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, Suhy J, Forrestal F, Tian Y, Umans K, Wang G, Singhal P, Budd Haeberlein S, Smirnakis K (2022) Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol 79(1):13\u201321. https:\/\/doi.org\/10.1001\/JAMANEUROL.2021.4161","journal-title":"JAMA Neurol"},{"issue":"2","key":"1761_CR79","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/J.EXPNEUROL.2011.11.036","volume":"233","author":"DB Santos","year":"2012","unstructured":"Santos DB, Peres KC, Ribeiro RP, Colle D, Santos AAdos, Moreira ELG, Souza DOG, Figueiredo CP, Farina M (2012) Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid \u03b2 peptide in mice. Exp Neurol 233(2):767\u2013775. https:\/\/doi.org\/10.1016\/J.EXPNEUROL.2011.11.036","journal-title":"Exp Neurol"},{"key":"1761_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/FNINS.2021.628403","volume":"15","author":"SB Scheinman","year":"2021","unstructured":"Scheinman SB, Zaldua S, Dada A, Krochmaliuk K, Dye K, Marottoli FM, Thatcher GRJ, Tai LM (2021) Systemic candesartan treatment modulates behavior, synaptic protein levels, and neuroinflammation in female mice that express human APOE4. Front Neurosci 15:628403. https:\/\/doi.org\/10.3389\/FNINS.2021.628403","journal-title":"Front Neurosci"},{"issue":"1","key":"1761_CR81","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/J.JACL.2019.12.010","volume":"14","author":"N Setia","year":"2020","unstructured":"Setia N, Movva S, Balakrishnan P, Biji IK, Sawhney JPS, Puri R, Arora A, Puri RD, Saxena R, Mishra S, Apte S, Kulshrestha S, Ramprasad VL, Verma IC (2020) Genetic analysis of familial hypercholesterolemia in Asian Indians: a single-center study. J Clin Lipidol 14(1):35\u201345. https:\/\/doi.org\/10.1016\/J.JACL.2019.12.010","journal-title":"J Clin Lipidol"},{"key":"1761_CR82","doi-asserted-by":"publisher","first-page":"543","DOI":"10.9734\/jpri\/2021\/v33i59b34413","volume":"33","author":"DAH Sheeba","year":"2021","unstructured":"Sheeba DAH, Gandhimathi R (2021) An overview on hyperlipidemia. J Pharm Res Int 33:543\u2013555. https:\/\/doi.org\/10.9734\/jpri\/2021\/v33i59b34413","journal-title":"J Pharm Res Int"},{"key":"1761_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/J.PNPBP.2020.109884","volume":"100","author":"H Shen","year":"2020","unstructured":"Shen H, Guan Q, Zhang X, Yuan C, Tan Z, Zhai L, Hao Y, Gu Y, Han C (2020) New mechanism of neuroinflammation in Alzheimer\u2019s disease: the activation of NLRP3 inflammasome mediated by gut microbiota. Prog Neuropsychopharmacol Biol Psychiatry 100:109884. https:\/\/doi.org\/10.1016\/J.PNPBP.2020.109884","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"7673","key":"1761_CR84","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/NATURE24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, Tsai RM, Spina S, Grinberg LT, Rojas JC, Gallardo G, Wang K, Roh J, Robinson G, Finn MB, Jiang H, Sullivan PM, Baufeld C, Wood MW, Holtzman DM (2017) APOE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549(7673):523\u2013527. https:\/\/doi.org\/10.1038\/NATURE24016","journal-title":"Nature"},{"issue":"12","key":"1761_CR85","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata M, Yamada S, Ram Kumar S, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, v. Zlokovic B (2000) Clearance of Alzheimer\u2019s amyloid-\u03b21-40 peptide from brain by LDL receptor\u2013related protein-1 at the blood-brain barrier. J Clin Invest 106(12):1489\u20131499","journal-title":"J Clin Invest"},{"issue":"7","key":"1761_CR86","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1194\/JLR.R075796","volume":"58","author":"M Shinohara","year":"2017","unstructured":"Shinohara M, Tachibana M, Kanekiyo T, Bu G (2017) Role of LRP1 in the pathogenesis of Alzheimer\u2019s disease: evidence from clinical and preclinical studies: thematic review series: ApoE and lipid homeostasis in Alzheimer\u2019s disease. J Lipid Res 58(7):1267\u20131281. https:\/\/doi.org\/10.1194\/JLR.R075796","journal-title":"J Lipid Res"},{"issue":"6","key":"1761_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS20061488","volume":"20","author":"M Shinohara","year":"2019","unstructured":"Shinohara M, Shinohara M, Zhao J, Fu Y, Liu CC, Kanekiyo T, Bu G (2019) 5-HT3 antagonist ondansetron increases APOE secretion by modulating the LXR-ABCA1 pathway. Int J Mol Sci 20(6):1488. https:\/\/doi.org\/10.3390\/IJMS20061488","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1761_CR88","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3233\/JAD-190074","volume":"70","author":"S Simonovitch","year":"2019","unstructured":"Simonovitch S, Schmukler E, Masliah E, Pinkas-Kramarski R, Michaelson DM (2019) The effects of APOE4 on mitochondrial dynamics and proteins in vivo. J Alzheimers Dis 70(3):861\u2013875. https:\/\/doi.org\/10.3233\/JAD-190074","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"1761_CR89","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.2215371120","volume":"120","author":"MD Stuchell-Brereton","year":"2023","unstructured":"Stuchell-Brereton MD, Zimmerman MI, Miller JJ, Mallimadugula UL, Incicco JJ, Roy D, Smith LG, Cubuk J, Baban B, DeKoster GT, Frieden C, Bowman GR, Soranno A (2023) Apolipoprotein E4 has extensive conformational heterogeneity in lipid-free and lipid-bound forms. Proc Natl Acad Sci U S A 120(7):e2215371120. https:\/\/doi.org\/10.1073\/PNAS.2215371120","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"29","key":"1761_CR90","doi-asserted-by":"publisher","first-page":"17972","DOI":"10.1074\/jbc.272.29.17972","volume":"272","author":"PM Sullivan","year":"1997","unstructured":"Sullivan PM, Mezdour H, Aratani Y, Knouff C, Najib J, Reddick RL, Quarfordt SH, Maeda N (1997) Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem 272(29):17972\u201317980. https:\/\/doi.org\/10.1074\/jbc.272.29.17972","journal-title":"J Biol Chem"},{"issue":"7","key":"1761_CR91","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1007\/S10571-023-01365-1","volume":"43","author":"YY Sun","year":"2023","unstructured":"Sun YY, Wang Z, Huang HC (2023) Roles of APOE4 on the pathogenesis in Alzheimer\u2019s disease and the potential therapeutic approaches. Cell Mol Neurobiol 43(7):3115\u20133136. https:\/\/doi.org\/10.1007\/S10571-023-01365-1","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"1761_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S11658-017-0059-8\/TABLES\/4","volume":"22","author":"A Suvatha","year":"2017","unstructured":"Suvatha A, Kandi SM, Bhat DI, Rao N, Vazhayil V, Kasturirangan CG (2017) Apolipoprotein E polymorphism and the risk of aneurysmal subarachnoid hemorrhage in a South Indian population. Cell Mol Biol Lett 22(1):1\u201310. https:\/\/doi.org\/10.1186\/S11658-017-0059-8\/TABLES\/4","journal-title":"Cell Mol Biol Lett"},{"issue":"4","key":"1761_CR93","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/JNC.13072","volume":"133","author":"LM Tai","year":"2015","unstructured":"Tai LM, Ghura S, Koster KP, Liakaite V, Maienschein-Cline M, Kanabar P, Collins N, Ben-Aissa M, Lei AZ, Bahroos N, Green SJ, Hendrickson B, van Eldik LJ, LaDu MJ (2015) APOE-modulated A\u03b2-induced neuroinflammation in Alzheimer\u2019s disease: current landscape, novel data, and future perspective. J Neurochem 133(4):465\u2013488. https:\/\/doi.org\/10.1111\/JNC.13072","journal-title":"J Neurochem"},{"issue":"7","key":"1761_CR94","doi-asserted-by":"publisher","DOI":"10.1096\/FJ.201900071R","volume":"33","author":"TTT Tran","year":"2019","unstructured":"Tran TTT, Corsini S, Kellingray L, Hegarty C, le Gall G, Narbad A, M\u00fcller M, Tejera N, O\u2019Toole PW, Minihane AM, Vauzour D (2019) APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer\u2019s disease pathophysiology. FASEB J 33(7):8221. https:\/\/doi.org\/10.1096\/FJ.201900071R","journal-title":"FASEB J"},{"issue":"5","key":"1761_CR95","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang C, Najm R, Xu Q, Jeong D, Walker D, Balestra ME, Yoon SY, Yuan H, Li G, Miller ZA, Miller BL, Malloy MJ, Huang Y (2018) Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat Med 24(5):647\u2013657. https:\/\/doi.org\/10.1038\/s41591-018-0004-z","journal-title":"Nat Med"},{"issue":"7","key":"1761_CR96","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1002\/ALZ.14052","volume":"20","author":"YZ Wang","year":"2024","unstructured":"Wang YZ, Zhao W, Moorjani P, Gross AL, Zhou X, Dey AB, Lee J, Smith JA, Kardia SLR (2024) Effect of apolipoprotein E \u03b54 and its modification by sociodemographic characteristics on cognitive measures in South Asians from LASI-DAD. Alzheimers Dement 20(7):4854\u20134867. https:\/\/doi.org\/10.1002\/ALZ.14052","journal-title":"Alzheimers Dement"},{"key":"1761_CR97","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0065-3233(08)60642-7","volume":"45","author":"KH Weisgraber","year":"1994","unstructured":"Weisgraber KH (1994) Apolipoprotein E: structure-function relationships. Adv Protein Chem 45:249\u2013302. https:\/\/doi.org\/10.1016\/S0065-3233(08)60642-7","journal-title":"Adv Protein Chem"},{"key":"1761_CR98","doi-asserted-by":"publisher","DOI":"10.7554\/ELIFE.40048","author":"X Xian","year":"2018","unstructured":"Xian X, Pohlkamp T, Durakoglugil MS, Wong CH, Beck JK, Lane-Donovan C, Plattner F, Herz J (2018) Reversal of APOE4-induced recycling block as a novel prevention approach for Alzheimer\u2019s disease. Elife. https:\/\/doi.org\/10.7554\/ELIFE.40048","journal-title":"Elife"},{"issue":"8","key":"1761_CR99","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/J.TEM.2023.05.002","volume":"34","author":"LG Yang","year":"2023","unstructured":"Yang LG, March ZM, Stephenson RA, Narayan PS (2023) Apolipoprotein E in lipid metabolism and neurodegenerative disease. Trends Endocrinol Metab 34(8):430\u2013445. https:\/\/doi.org\/10.1016\/J.TEM.2023.05.002","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"1761_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS22031244","volume":"22","author":"A Yang","year":"2021","unstructured":"Yang A, Kantor B, Chiba-Falek O (2021) APOE: the new frontier in the development of a therapeutic target towards precision medicine in late-onset Alzheimer\u2019s. Int J Mol Sci 22(3):1244. https:\/\/doi.org\/10.3390\/IJMS22031244","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1761_CR101","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1001\/JAMANEUROL.2016.4899","volume":"74","author":"HN Yassine","year":"2017","unstructured":"Yassine HN, Braskie MN, Mack WJ, Castor KJ, Fonteh AN, Schneider LS, Harrington MG, Chui HC (2017) Association of docosahexaenoic acid supplementation with Alzheimer disease stage in Apolipoprotein E \u03b54 carriers: a review. JAMA Neurol 74(3):339\u2013347. https:\/\/doi.org\/10.1001\/JAMANEUROL.2016.4899","journal-title":"JAMA Neurol"},{"issue":"50","key":"1761_CR102","doi-asserted-by":"publisher","first-page":"41774","DOI":"10.1074\/jbc.M112.407957","volume":"287","author":"KL Youmans","year":"2012","unstructured":"Youmans KL, Tai LM, Nwabuisi-Heath E, Jungbauer L, Kanekiyo T, Gan M, Kim J, Eimer WA, Estus S, Rebeck GW, Weeber EJ, Bu G, Yu C, LaDu MJ (2012) APOE4-specific changes in A\u03b2 accumulation in a new transgenic mouse model of alzheimer disease. J Biol Chem 287(50):41774\u201341786. https:\/\/doi.org\/10.1074\/jbc.M112.407957","journal-title":"J Biol Chem"},{"key":"1761_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/FNAGI.2023.1199434","volume":"15","author":"L Zhang","year":"2023","unstructured":"Zhang L, Xia Y, Gui Y (2023) Neuronal APOE4 in Alzheimer\u2019s disease and potential therapeutic targets. Front Aging Neurosci 15:1199434. https:\/\/doi.org\/10.3389\/FNAGI.2023.1199434","journal-title":"Front Aging Neurosci"},{"key":"1761_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBRC.2025.152335","volume":"778","author":"WX Zhang","year":"2025","unstructured":"Zhang WX, Yang YL, Yu JX, Jia LH, Huang HC (2025) APOE4-driven lipid metabolic dysregulation in Alzheimer\u2019s disease: multi-pathway mechanisms and therapeutic perspectives. Biochem Biophys Res Commun 778:152335. https:\/\/doi.org\/10.1016\/J.BBRC.2025.152335","journal-title":"Biochem Biophys Res Commun"},{"key":"1761_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/S41467-020-19264-0","author":"J Zhao","year":"2020","unstructured":"Zhao J, Fu Y, Yamazaki Y, Ren Y, Davis MD, Liu CC, Lu W, Wang X, Chen K, Cherukuri Y, Jia L, Martens YA, Job L, Shue F, Nguyen TT, Younkin SG, Graff-Radford NR, Wszolek ZK, Brafman DA, Bu G (2020) APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer\u2019s disease patient iPSC-derived cerebral organoids. Nat Commun. https:\/\/doi.org\/10.1038\/S41467-020-19264-0","journal-title":"Nat Commun"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01761-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-025-01761-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01761-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T07:37:36Z","timestamp":1766475456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-025-01761-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1761"],"URL":"https:\/\/doi.org\/10.1007\/s11011-025-01761-0","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}